BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fields GB. The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma. Cells 2019;8:E984. [PMID: 31461880 DOI: 10.3390/cells8090984] [Cited by in Crossref: 76] [Cited by in F6Publishing: 69] [Article Influence: 25.3] [Reference Citation Analysis]
Number Citing Articles
1 Onwuha‐ekpete L, Fields GB. Application of a triple‐helical peptide inhibitor of MMP ‐2/ MMP ‐9 to examine T‐cell activation in experimental autoimmune encephalomyelitis. Peptide Science. [DOI: 10.1002/pep2.24262] [Reference Citation Analysis]
2 Sandha KK, Shukla MK, Gupta PN. Recent Advances in Strategies for Extracellular Matrix Degradation and Synthesis Inhibition for Improved Therapy of Solid Tumors. CPD 2020;26:5456-67. [DOI: 10.2174/1381612826666200728141601] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Das S, Amin SA, Jha T. Insight into the structural requirement of aryl sulphonamide based gelatinases (MMP-2 and MMP-9) inhibitors - Part I: 2D-QSAR, 3D-QSAR topomer CoMFA and Naïve Bayes studies - First report of 3D-QSAR Topomer CoMFA analysis for MMP-9 inhibitors and jointly inhibitors of gelatinases together. SAR QSAR Environ Res 2021;32:655-87. [PMID: 34355614 DOI: 10.1080/1062936X.2021.1955414] [Reference Citation Analysis]
4 Lin H, Xu P, Huang M. Structure-based molecular insights into matrix metalloproteinase inhibitors in cancer treatments. Future Med Chem 2021;:0. [PMID: 34779649 DOI: 10.4155/fmc-2021-0246] [Reference Citation Analysis]
5 Weinreb RN, Robinson MR, Dibas M, Stamer WD. Matrix Metalloproteinases and Glaucoma Treatment. J Ocul Pharmacol Ther 2020;36:208-28. [PMID: 32233938 DOI: 10.1089/jop.2019.0146] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
6 Karamanos NK, Piperigkou Z, Passi A, Götte M, Rousselle P, Vlodavsky I. Extracellular matrix-based cancer targeting. Trends Mol Med 2021:S1471-4914(21)00190-8. [PMID: 34389240 DOI: 10.1016/j.molmed.2021.07.009] [Reference Citation Analysis]
7 Lenci E, Angeli A, Calugi L, Innocenti R, Carta F, Supuran CT, Trabocchi A. Multitargeting application of proline-derived peptidomimetics addressing cancer-related human matrix metalloproteinase 9 and carbonic anhydrase II. Eur J Med Chem 2021;214:113260. [PMID: 33581552 DOI: 10.1016/j.ejmech.2021.113260] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zipfel P, Rochais C, Baranger K, Rivera S, Dallemagne P. Matrix Metalloproteinases as New Targets in Alzheimer's Disease: Opportunities and Challenges. J Med Chem. 2020;63:10705-10725. [PMID: 32459966 DOI: 10.1021/acs.jmedchem.0c00352] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
9 Shoari A, Kanavi MR, Rasaee MJ. Inhibition of matrix metalloproteinase-9 for the treatment of dry eye syndrome; a review study. Exp Eye Res 2021;205:108523. [PMID: 33662353 DOI: 10.1016/j.exer.2021.108523] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Das N, Benko C, Gill SE, Dufour A. The Pharmacological TAILS of Matrix Metalloproteinases and Their Inhibitors. Pharmaceuticals (Basel) 2020;14:31. [PMID: 33396445 DOI: 10.3390/ph14010031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Del Giudice S, De Luca V, Parizadeh S, Russo D, Luini A, Di Martino R. Endogenous and Exogenous Regulatory Signaling in the Secretory Pathway: Role of Golgi Signaling Molecules in Cancer. Front Cell Dev Biol 2022;10:833663. [DOI: 10.3389/fcell.2022.833663] [Reference Citation Analysis]
12 Rocchi D, Blázquez-Barbadillo C, Agamennone M, Laghezza A, Tortorella P, Vicente-Zurdo D, Rosales-Conrado N, Moyano P, Pino JD, González JF, Menéndez JC. Discovery of 7-aminophenanthridin-6-one as a new scaffold for matrix metalloproteinase inhibitors with multitarget neuroprotective activity. Eur J Med Chem 2021;210:113061. [PMID: 33310289 DOI: 10.1016/j.ejmech.2020.113061] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Lenci E, Cosottini L, Trabocchi A. Novel matrix metalloproteinase inhibitors: an updated patent review (2014 - 2020). Expert Opin Ther Pat 2021;31:509-23. [PMID: 33487088 DOI: 10.1080/13543776.2021.1881481] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Tang Y, Zhu L, Cho JS, Li XY, Weiss SJ. Matrix remodeling controls a nuclear lamin A/C-emerin network that directs Wnt-regulated stem cell fate. Dev Cell 2022:S1534-5807(22)00040-5. [PMID: 35150612 DOI: 10.1016/j.devcel.2022.01.015] [Reference Citation Analysis]
15 Laronha H, Carpinteiro I, Portugal J, Azul A, Polido M, Petrova KT, Salema-Oom M, Caldeira J. Challenges in Matrix Metalloproteinases Inhibition. Biomolecules 2020;10:E717. [PMID: 32380782 DOI: 10.3390/biom10050717] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
16 Deryugina E, Carré A, Ardi V, Muramatsu T, Schmidt J, Pham C, Quigley JP. Neutrophil Elastase Facilitates Tumor Cell Intravasation and Early Metastatic Events. iScience 2020;23:101799. [PMID: 33299970 DOI: 10.1016/j.isci.2020.101799] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
17 Li K, Tay FR, Yiu CKY. The past, present and future perspectives of matrix metalloproteinase inhibitors. Pharmacology & Therapeutics 2020;207:107465. [DOI: 10.1016/j.pharmthera.2019.107465] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 17.5] [Reference Citation Analysis]
18 Morla S, Desai UR. Discovery of Sulfated Small Molecule Inhibitors of Matrix Metalloproteinase-8. Biomolecules 2020;10:E1166. [PMID: 32784891 DOI: 10.3390/biom10081166] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
19 Orset C, Arkelius K, Anfray A, Warfvinge K, Vivien D, Ansar S. Combination treatment with U0126 and rt-PA prevents adverse effects of the delayed rt-PA treatment after acute ischemic stroke. Sci Rep 2021;11:11993. [PMID: 34099834 DOI: 10.1038/s41598-021-91469-9] [Reference Citation Analysis]
20 Gorter RP, Baron W. Matrix metalloproteinases shape the oligodendrocyte (niche) during development and upon demyelination. Neurosci Lett 2020;729:134980. [PMID: 32315713 DOI: 10.1016/j.neulet.2020.134980] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
21 Al-Awadhi FH, Luesch H. Targeting eukaryotic proteases for natural products-based drug development. Nat Prod Rep 2020;37:827-60. [PMID: 32519686 DOI: 10.1039/c9np00060g] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
22 Das S, Amin SA, Jha T. Inhibitors of gelatinases (MMP-2 and MMP-9) for the management of hematological malignancies. Eur J Med Chem 2021;223:113623. [PMID: 34157437 DOI: 10.1016/j.ejmech.2021.113623] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Ronsisvalle S, Panarello F, Longhitano G, Siciliano EA, Montenegro L, Panico A. Natural Flavones and Flavonols: Relationships among Antioxidant Activity, Glycation, and Metalloproteinase Inhibition. Cosmetics 2020;7:71. [DOI: 10.3390/cosmetics7030071] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
24 Niland S, Eble JA. Hold on or Cut? Integrin- and MMP-Mediated Cell-Matrix Interactions in the Tumor Microenvironment. Int J Mol Sci 2020;22:E238. [PMID: 33379400 DOI: 10.3390/ijms22010238] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
25 Asif PJ, Longobardi C, Hahne M, Medema JP. The Role of Cancer-Associated Fibroblasts in Cancer Invasion and Metastasis. Cancers (Basel) 2021;13:4720. [PMID: 34572947 DOI: 10.3390/cancers13184720] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 McClurg O, Tinson R, Troeberg L. Targeting Cartilage Degradation in Osteoarthritis. Pharmaceuticals (Basel) 2021;14:126. [PMID: 33562742 DOI: 10.3390/ph14020126] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
27 Waller V, Pruschy M. Combined Radiochemotherapy: Metalloproteinases Revisited. Front Oncol 2021;11:676583. [PMID: 34055644 DOI: 10.3389/fonc.2021.676583] [Reference Citation Analysis]
28 Llorente P, Mejías V, Sastre I, Recuero M, Aldudo J, Bullido MJ. Matrix metalloproteinase 14 regulates HSV-1 infection in neuroblastoma cells. Antiviral Res 2021;192:105116. [PMID: 34107282 DOI: 10.1016/j.antiviral.2021.105116] [Reference Citation Analysis]
29 Poole AT, Sitko CA, Le C, Naus CC, Hill BM, Bushnell EAC, Chen VC. Examination of sulfonamide-based inhibitors of MMP3 using the conditioned media of invasive glioma cells. J Enzyme Inhib Med Chem 2020;35:672-81. [PMID: 32156166 DOI: 10.1080/14756366.2020.1715387] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Long Z. Computational analysis of the metal selectivity of matrix metalloproteinase 8. PLoS One 2020;15:e0243321. [PMID: 33275641 DOI: 10.1371/journal.pone.0243321] [Reference Citation Analysis]
31 Van Doren SR. MMP-7 marks severe pancreatic cancer and alters tumor cell signaling by proteolytic release of ectodomains. Biochem Soc Trans 2022:BST20210640. [PMID: 35343563 DOI: 10.1042/BST20210640] [Reference Citation Analysis]
32 Vernerey FJ, Lalitha Sridhar S, Muralidharan A, Bryant SJ. Mechanics of 3D Cell-Hydrogel Interactions: Experiments, Models, and Mechanisms. Chem Rev 2021;121:11085-148. [PMID: 34473466 DOI: 10.1021/acs.chemrev.1c00046] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Wang L, Han H, Wang Z, Shi L, Yang M, Qin Y. Targeting the Microenvironment in Esophageal Cancer. Front Cell Dev Biol 2021;9:684966. [PMID: 34513829 DOI: 10.3389/fcell.2021.684966] [Reference Citation Analysis]
34 Tune BXJ, Sim MS, Poh CL, Guad RM, Woon CK, Hazarika I, Das A, Gopinath SCB, Rajan M, Sekar M, Subramaniyan V, Fuloria NK, Fuloria S, Batumalaie K, Wu YS, Zheng D. Matrix Metalloproteinases in Chemoresistance: Regulatory Roles, Molecular Interactions, and Potential Inhibitors. Journal of Oncology 2022;2022:1-25. [DOI: 10.1155/2022/3249766] [Reference Citation Analysis]
35 Sell SL, Prough DS, Weisz HA, Widen SG, Hellmich HL. Leveraging publicly available coronavirus data to identify new therapeutic targets for COVID-19. PLoS One 2021;16:e0257965. [PMID: 34587192 DOI: 10.1371/journal.pone.0257965] [Reference Citation Analysis]
36 Wu PS, Wang CY, Chen PS, Hung JH, Yen JH, Wu MJ. 8-Hydroxydaidzein Downregulates JAK/STAT, MMP, Oxidative Phosphorylation, and PI3K/AKT Pathways in K562 Cells. Biomedicines 2021;9:1907. [PMID: 34944720 DOI: 10.3390/biomedicines9121907] [Reference Citation Analysis]
37 Slapak EJ, Duitman J, Tekin C, Bijlsma MF, Spek CA. Matrix Metalloproteases in Pancreatic Ductal Adenocarcinoma: Key Drivers of Disease Progression? Biology (Basel) 2020;9:E80. [PMID: 32325664 DOI: 10.3390/biology9040080] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
38 Raskov H, Orhan A, Salanti A, Gaggar S, Gögenur I. Natural Killer Cells in Cancer and Cancer Immunotherapy. Cancer Lett 2021;520:233-42. [PMID: 34302920 DOI: 10.1016/j.canlet.2021.07.032] [Reference Citation Analysis]
39 Abd Al Moaty MN, El Ashry ESH, Awad LF, Ibrahim NA, Abu-serie MM, Barakat A, Altowyan MS, Teleb M. Enhancing the Anticancer Potential of Targeting Tumor-Associated Metalloenzymes via VEGFR Inhibition by New Triazolo[4,3-a]pyrimidinone Acyclo C-Nucleosides Multitarget Agents. Molecules 2022;27:2422. [DOI: 10.3390/molecules27082422] [Reference Citation Analysis]
40 Hou S, Diez J, Wang C, Becker-Pauly C, Fields GB, Bannister T, Spicer TP, Scampavia LD, Minond D. Discovery and Optimization of Selective Inhibitors of Meprin α (Part I). Pharmaceuticals (Basel) 2021;14:203. [PMID: 33671080 DOI: 10.3390/ph14030203] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
41 Rudzińska M, Daglioglu C, Savvateeva LV, Kaci FN, Antoine R, Zamyatnin AA Jr. Current Status and Perspectives of Protease Inhibitors and Their Combination with Nanosized Drug Delivery Systems for Targeted Cancer Therapy. Drug Des Devel Ther 2021;15:9-20. [PMID: 33442233 DOI: 10.2147/DDDT.S285852] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
42 Sheehan G, Konings M, Lim W, Fahal A, Kavanagh K, van de Sande WWJ. Proteomic analysis of the processes leading to Madurella mycetomatis grain formation in Galleria mellonella larvae. PLoS Negl Trop Dis 2020;14:e0008190. [PMID: 32267851 DOI: 10.1371/journal.pntd.0008190] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
43 Li X, Gu J, Xiao Q, Liu Y, Zhou P, Fan L, Zhang X, Lu X, Wu J, Liu Z, He W. Liposomal codelivery of inflammation inhibitor and collagen protector to the plaque for effective anti-atherosclerosis. Chinese Chemical Letters 2022. [DOI: 10.1016/j.cclet.2022.04.081] [Reference Citation Analysis]
44 Park KC, Dharmasivam M, Richardson DR. The Role of Extracellular Proteases in Tumor Progression and the Development of Innovative Metal Ion Chelators that Inhibit their Activity. Int J Mol Sci 2020;21:E6805. [PMID: 32948029 DOI: 10.3390/ijms21186805] [Reference Citation Analysis]
45 Oo WM, Hunter DJ. Repurposed and investigational disease-modifying drugs in osteoarthritis (DMOADs). Therapeutic Advances in Musculoskeletal 2022;14:1759720X2210902. [DOI: 10.1177/1759720x221090297] [Reference Citation Analysis]
46 Middleton JD, Sivakumar S, Hai T. Chemotherapy-Induced Changes in the Lung Microenvironment: The Role of MMP-2 in Facilitating Intravascular Arrest of Breast Cancer Cells. Int J Mol Sci 2021;22:10280. [PMID: 34638621 DOI: 10.3390/ijms221910280] [Reference Citation Analysis]
47 Reda Aouad M, Almehmadi MA, Faleh Albelwi F, Teleb M, Tageldin GN, Abu-serie MM, Hagar M, Rezki N. Targeting the interplay between MMP-2, CA II and VEGFR-2 via new sulfonamide-tethered isomeric triazole hybrids; Microwave-assisted synthesis, computational studies and evaluation. Bioorganic Chemistry 2022. [DOI: 10.1016/j.bioorg.2022.105816] [Reference Citation Analysis]
48 Krug S, Parveen S, Bishai WR. Host-Directed Therapies: Modulating Inflammation to Treat Tuberculosis. Front Immunol 2021;12:660916. [PMID: 33953722 DOI: 10.3389/fimmu.2021.660916] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
49 Bussies PL, Richards EG, Rotz SJ, Falcone T. Targeted cancer treatment and fertility: effect of immunotherapy and small molecule inhibitors on female reproduction. Reprod Biomed Online 2021:S1472-6483(21)00434-X. [PMID: 34674940 DOI: 10.1016/j.rbmo.2021.09.004] [Reference Citation Analysis]
50 Peralta S, Duhamel GE, Katt WP, Heikinheimo K, Miller AD, Ahmed F, McCleary-Wheeler AL, Grenier JK. Comparative transcriptional profiling of canine acanthomatous ameloblastoma and homology with human ameloblastoma. Sci Rep 2021;11:17792. [PMID: 34493785 DOI: 10.1038/s41598-021-97430-0] [Reference Citation Analysis]
51 Wang P, Gong Q, Hu J, Li X, Zhang X. Reactive Oxygen Species (ROS)-Responsive Prodrugs, Probes, and Theranostic Prodrugs: Applications in the ROS-Related Diseases. J Med Chem 2021;64:298-325. [PMID: 33356214 DOI: 10.1021/acs.jmedchem.0c01704] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
52 Latourte A, Richette P. Inhibition of ADAMTS-5: the right target for osteoarthritis? Osteoarthritis Cartilage 2021:S1063-4584(21)00917-1. [PMID: 34624506 DOI: 10.1016/j.joca.2021.09.012] [Reference Citation Analysis]
53 Liu S, Yan L, Zhang Y, Junaid M, Wang J. Polystyrene nanoplastics exacerbated the ecotoxicological and potential carcinogenic effects of tetracycline in juvenile grass carp (Ctenopharyngodon idella). Sci Total Environ 2021;803:150027. [PMID: 34482139 DOI: 10.1016/j.scitotenv.2021.150027] [Reference Citation Analysis]
54 Martu MA, Maftei GA, Luchian I, Stefanescu OM, Scutariu MM, Solomon SM. The Effect of Acknowledged and Novel Anti-Rheumatic Therapies on Periodontal Tissues-A Narrative Review. Pharmaceuticals (Basel) 2021;14:1209. [PMID: 34959607 DOI: 10.3390/ph14121209] [Reference Citation Analysis]
55 Lenci E, Contini A, Trabocchi A. Discovery of a d-pro-lys peptidomimetic inhibitor of MMP9: Addressing the gelatinase selectivity beyond S1′ subsite. Bioorganic & Medicinal Chemistry Letters 2020;30:127467. [DOI: 10.1016/j.bmcl.2020.127467] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
56 Ritchie S, Reed DA, Pereira BA, Timpson P. The cancer cell secretome drives cooperative manipulation of the tumour microenvironment to accelerate tumourigenesis. Fac Rev 2021;10:4. [PMID: 33659922 DOI: 10.12703/r/10-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
57 Martinez-Vidal L, Murdica V, Venegoni C, Pederzoli F, Bandini M, Necchi A, Salonia A, Alfano M. Causal contributors to tissue stiffness and clinical relevance in urology. Commun Biol 2021;4:1011. [PMID: 34446834 DOI: 10.1038/s42003-021-02539-7] [Reference Citation Analysis]
58 Geervliet E, Bansal R. Matrix Metalloproteinases as Potential Biomarkers and Therapeutic Targets in Liver Diseases. Cells. 2020;9. [PMID: 32414178 DOI: 10.3390/cells9051212] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
59 Guarise C, Ceradini D, Tessari M, Pavan M, Moro S, Salmaso V, Barbera C, Beninatto R, Galesso D. Amphiphilic peptide-based MMP3 inhibitors for intra-articular treatment of knee OA. Bioorg Med Chem 2021;38:116132. [PMID: 33872958 DOI: 10.1016/j.bmc.2021.116132] [Reference Citation Analysis]
60 Ouyang X, Feng L, Yao L, Xiao Y, Hu X, Zhang G, Liu G, Wang Z. Testicular orphan receptor 4 (TR4) promotes papillary thyroid cancer invasion via activating circ-FNLA/miR-149-5p/MMP9 signaling. Mol Ther Nucleic Acids 2021;24:755-67. [PMID: 33996257 DOI: 10.1016/j.omtn.2021.03.021] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
61 Chang YC, Hahn RA, Gordon MK, Laskin JD, Gerecke DR. A type IV collagenase inhibitor, N-hydroxy-3-phenyl-2-(4-phenylbenzenesulfonamido) propanamide (BiPS), suppresses skin injury induced by sulfur mustard. Toxicol Appl Pharmacol 2020;401:115078. [PMID: 32479919 DOI: 10.1016/j.taap.2020.115078] [Reference Citation Analysis]
62 Li H, Ma RQ, Cheng HY, Ye X, Zhu HL, Chang XH. Fibrinogen alpha chain promotes the migration and invasion of human endometrial stromal cells in endometriosis through focal adhesion kinase/protein kinase B/matrix metallopeptidase 2 pathway†. Biol Reprod 2020;103:779-90. [PMID: 32697296 DOI: 10.1093/biolre/ioaa126] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
63 Laleu B, Akao Y, Ochida A, Duffy S, Lucantoni L, Shackleford DM, Chen G, Katneni K, Chiu FCK, White KL, Chen X, Sturm A, Dechering KJ, Crespo B, Sanz LM, Wang B, Wittlin S, Charman SA, Avery VM, Cho N, Kamaura M. Discovery and Structure-Activity Relationships of Quinazolinone-2-carboxamide Derivatives as Novel Orally Efficacious Antimalarials. J Med Chem 2021;64:12582-602. [PMID: 34437804 DOI: 10.1021/acs.jmedchem.1c00441] [Reference Citation Analysis]
64 La Russa R, Maiese A, Di Fazio N, Morano A, Di Bonaventura C, De Matteis A, Fazio V, Frati P, Fineschi V. Post-Traumatic Meningitis Is a Diagnostic Challenging Time: A Systematic Review Focusing on Clinical and Pathological Features. Int J Mol Sci 2020;21:E4148. [PMID: 32532024 DOI: 10.3390/ijms21114148] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
65 Leong E, Bezuhly M, Marshall JS. Distinct Metalloproteinase Expression and Functions in Systemic Sclerosis and Fibrosis: What We Know and the Potential for Intervention. Front Physiol 2021;12:727451. [PMID: 34512395 DOI: 10.3389/fphys.2021.727451] [Reference Citation Analysis]
66 Das S, Amin SA, Gayen S, Jha T. Insight into the structural requirements of gelatinases (MMP-2 and MMP-9) inhibitors by multiple validated molecular modelling approaches: Part II. SAR QSAR Environ Res 2022;33:167-92. [PMID: 35301933 DOI: 10.1080/1062936X.2022.2041722] [Reference Citation Analysis]
67 Virtuoso A, De Luca C, Gargano F, Colangelo AM, Papa M. The Spinal Extracellular Matrix Modulates a Multi-level Protein Net and Epigenetic Inducers Following Peripheral Nerve Injury. Neuroscience 2020;451:216-25. [DOI: 10.1016/j.neuroscience.2020.09.051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
68 Mgrditchian T, Sakalauskaite G, Müller T, Hoffmann C, Thomas C. The multiple roles of actin-binding proteins at invadopodia. Int Rev Cell Mol Biol 2021;360:99-132. [PMID: 33962752 DOI: 10.1016/bs.ircmb.2021.03.004] [Reference Citation Analysis]
69 Fejza A, Camicia L, Poletto E, Carobolante G, Mongiat M, Andreuzzi E. ECM Remodeling in Squamous Cell Carcinoma of the Aerodigestive Tract: Pathways for Cancer Dissemination and Emerging Biomarkers. Cancers (Basel) 2021;13:2759. [PMID: 34199373 DOI: 10.3390/cancers13112759] [Reference Citation Analysis]
70 Begum Y, Pandit A, Swarnakar S. Insights Into the Regulation of Gynecological Inflammation-Mediated Malignancy by Metalloproteinases. Front Cell Dev Biol 2021;9:780510. [PMID: 34912809 DOI: 10.3389/fcell.2021.780510] [Reference Citation Analysis]
71 Lopes AG, de Almeida GC Jr, Miola MP, Teixeira RM, Pires FCBL, Miani RA, de Mattos LC, Brandão CC, Castiglioni L. Absence of significant genetic alterations in the VSX1, SOD1, TIMP3, and LOX genes in Brazilian patients with Keratoconus. Ophthalmic Genet 2021;:1-7. [PMID: 34802378 DOI: 10.1080/13816810.2021.1992785] [Reference Citation Analysis]
72 Li K, Jin R, Wu X. The role of macrophages and osteoclasts in the progression of leukemia. Hematology 2021;26:724-33. [PMID: 34555294 DOI: 10.1080/16078454.2021.1976911] [Reference Citation Analysis]
73 Dahmene M, Quirion L, Laurin M. High Throughput strategies Aimed at Closing the GAP in Our Knowledge of Rho GTPase Signaling. Cells 2020;9:E1430. [PMID: 32526908 DOI: 10.3390/cells9061430] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
74 Lee SY. Anti-Metastatic and Anti-Inflammatory Effects of Matrix Metalloproteinase Inhibition by Ginsenosides. Biomedicines 2021;9:198. [PMID: 33671187 DOI: 10.3390/biomedicines9020198] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
75 Oo WM. Prospects of Disease-Modifying Osteoarthritis Drugs. Clinics in Geriatric Medicine 2022;38:397-432. [DOI: 10.1016/j.cger.2021.11.010] [Reference Citation Analysis]
76 Eltayeb NM, Al-amin M, Yousif AM, Balakrishnan V, Salhimi SM. Catharanthus roseus L. extract downregulates the expression profile of motility-related genes in highly invasive human breast cancer cell line MDA-MB-231. Biologia 2021;76:1017-32. [DOI: 10.2478/s11756-020-00641-5] [Reference Citation Analysis]
77 Celentano A, Yap T, Paolini R, Yiannis C, Mirams M, Koo K, McCullough M, Cirillo N. Inhibition of matrix metalloproteinase-2 modulates malignant behaviour of oral squamous cell carcinoma cells. J Oral Pathol Med 2021;50:323-32. [PMID: 31925966 DOI: 10.1111/jop.12992] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
78 Agnew-francis KA, Williams CM. Squaramides as Bioisosteres in Contemporary Drug Design. Chem Rev 2020;120:11616-50. [DOI: 10.1021/acs.chemrev.0c00416] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
79 Valenti MT, Dalle Carbonare L, Zipeto D, Mottes M. Control of the Autophagy Pathway in Osteoarthritis: Key Regulators, Therapeutic Targets and Therapeutic Strategies. Int J Mol Sci 2021;22:2700. [PMID: 33800062 DOI: 10.3390/ijms22052700] [Reference Citation Analysis]
80 Kok HJ, Barton ER. Actions and interactions of IGF-I and MMPs during muscle regeneration. Semin Cell Dev Biol 2021:S1084-9521(21)00091-4. [PMID: 33962867 DOI: 10.1016/j.semcdb.2021.04.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
81 Laghezza A, Piemontese L, Brunetti L, Caradonna A, Agamennone M, Di Pizio A, Pochetti G, Montanari R, Capelli D, Tauro M, Loiodice F, Tortorella P. Bone-Seeking Matrix Metalloproteinase Inhibitors for the Treatment of Skeletal Malignancy. Pharmaceuticals (Basel) 2020;13:E113. [PMID: 32492898 DOI: 10.3390/ph13060113] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
82 Nyström A, Bruckner-Tuderman L, Kiritsi D. Dystrophic Epidermolysis Bullosa: Secondary Disease Mechanisms and Disease Modifiers. Front Genet 2021;12:737272. [PMID: 34650598 DOI: 10.3389/fgene.2021.737272] [Reference Citation Analysis]
83 Brebion F, Gosmini R, Deprez P, Varin M, Peixoto C, Alvey L, Jary H, Bienvenu N, Triballeau N, Blanque R, Cottereaux C, Christophe T, Vandervoort N, Mollat P, Touitou R, Leonard P, De Ceuninck F, Botez I, Monjardet A, van der Aar E, Amantini D. Discovery of GLPG1972/S201086, a Potent, Selective, and Orally Bioavailable ADAMTS-5 Inhibitor for the Treatment of Osteoarthritis. J Med Chem 2021;64:2937-52. [PMID: 33719441 DOI: 10.1021/acs.jmedchem.0c02008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
84 Kumar P, Siripini S, Sreedhar AS. The matrix metalloproteinase 7 (MMP7) links Hsp90 chaperone with acquired drug resistance and tumor metastasis. Cancer Rep (Hoboken) 2020;:e1261. [PMID: 32761892 DOI: 10.1002/cnr2.1261] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
85 Niland S, Riscanevo AX, Eble JA. Matrix Metalloproteinases Shape the Tumor Microenvironment in Cancer Progression. Int J Mol Sci 2021;23:146. [PMID: 35008569 DOI: 10.3390/ijms23010146] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
86 Mota J, Direito R, Rocha J, Fernandes J, Sepodes B, Figueira ME, Raymundo A, Lima A, Ferreira RB. Lupinus albus Protein Components Inhibit MMP-2 and MMP-9 Gelatinolytic Activity In Vitro and In Vivo. Int J Mol Sci 2021;22:13286. [PMID: 34948082 DOI: 10.3390/ijms222413286] [Reference Citation Analysis]
87 Mohan V, Gaffney JP, Solomonov I, Levin M, Klepfish M, Akbareian S, Grünwald B, Dym O, Eisenstein M, Yu KH, Kelsen DP, Krüger A, Edwards DR, Sagi I. Conformation-Specific Inhibitory Anti-MMP-7 Monoclonal Antibody Sensitizes Pancreatic Ductal Adenocarcinoma Cells to Chemotherapeutic Cell Kill. Cancers (Basel) 2021;13:1679. [PMID: 33918254 DOI: 10.3390/cancers13071679] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Ancona S, Orpianesi E, Bernardelli C, Chiaramonte E, Chiaramonte R, Terraneo S, Di Marco F, Lesma E. Differential Modulation of Matrix Metalloproteinases-2 and -7 in LAM/TSC Cells. Biomedicines 2021;9:1760. [PMID: 34944575 DOI: 10.3390/biomedicines9121760] [Reference Citation Analysis]
89 Gonzalez-molina J, Moyano-galceran L, Single A, Gultekin O, Alsalhi S, Lehti K. Chemotherapy as a regulator of extracellular matrix-cell communication: implications in therapy resistance. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.03.012] [Reference Citation Analysis]
90 Labarre A, Stille JK, Patrascu MB, Martins A, Pottel J, Moitessier N. Docking Ligands into Flexible and Solvated Macromolecules. 8. Forming New Bonds─Challenges and Opportunities. J Chem Inf Model 2022. [PMID: 35133156 DOI: 10.1021/acs.jcim.1c00701] [Reference Citation Analysis]
91 Laronha H, Carpinteiro I, Portugal J, Azul A, Polido M, Petrova KT, Salema-Oom M, Barahona I, Caldeira J. Polymerizable Matrix Metalloproteinases' Inhibitors with Potential Application for Dental Restorations. Biomedicines 2021;9:366. [PMID: 33807479 DOI: 10.3390/biomedicines9040366] [Reference Citation Analysis]
92 Elsässer B, Goettig P. Mechanisms of Proteolytic Enzymes and Their Inhibition in QM/MM Studies. Int J Mol Sci 2021;22:3232. [PMID: 33810118 DOI: 10.3390/ijms22063232] [Reference Citation Analysis]
93 Raeeszadeh-Sarmazdeh M, Do LD, Hritz BG. Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics. Cells. 2020;9. [PMID: 32466129 DOI: 10.3390/cells9051313] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 15.5] [Reference Citation Analysis]
94 Gamradt P, De La Fouchardière C, Hennino A. Stromal Protein-Mediated Immune Regulation in Digestive Cancers. Cancers (Basel) 2021;13:E146. [PMID: 33466303 DOI: 10.3390/cancers13010146] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
95 Anderson R, Blidner AG, Rapoport BL. Frontiers in Pharmacology: Review Manuscript Targeting of the Neutrophil as an Adjunctive Strategy in Non-Small Cell Lung Cancer. Front Pharmacol 2021;12:676399. [PMID: 34168563 DOI: 10.3389/fphar.2021.676399] [Reference Citation Analysis]
96 Zhang F, Liu E, Radaic A, Yu X, Yang S, Yu C, Xiao S, Ye C. Diagnostic potential and future directions of matrix metalloproteinases as biomarkers in gingival crevicular fluid of oral and systemic diseases. Int J Biol Macromol 2021;188:180-96. [PMID: 34339782 DOI: 10.1016/j.ijbiomac.2021.07.165] [Reference Citation Analysis]